SCHEMBL6153843

SCHEMBL6153843

COC(=O)CC(CC(=O)OC)OC(=O)Oc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
KMT2A Q03164 3/20 0.43
MAPT P10636 2/20 0.43
HSD17B10 Q99714 2/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
KCNA5 P22460 1/20 0.40
MTNR1A P48039 5/20 0.40
MTNR1B P49286 5/20 0.40
HPGD P15428 2/20 0.39
POLB P06746 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALOX15 P16050 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
MEN1 O00255 1/20 0.37
MIF P14174 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29250 0.78 HPGD (0.57) ALDH1A1KMT2AMAPTHSD17B10LMNA
SCHEMBL27496383 0.78 HPGD (0.57) ALDH1A1KMT2AMAPTHSD17B10LMNA
SCHEMBL6154377 0.78 TSHR (0.49) ALDH1A1KMT2AMAPTLMNAHTT
SCHEMBL6153580 0.78 ABCB1 (0.51) ALDH1A1KMT2ALMNAHTTKDM4E
SCHEMBL27917658 0.77 PPARG (0.42) ALDH1A1MAPTLMNAMTNR1AMTNR1B
SCHEMBL6537222 0.77 HPGD (0.55) ALDH1A1KMT2AMAPTHSD17B10LMNA
SCHEMBL27733071 0.77 ALDH1A1 (0.52) ALDH1A1KMT2AMAPTHSD17B10LMNA
SCHEMBL8231634 0.77 HPGD (0.55) ALDH1A1KMT2AMAPTHSD17B10LMNA
Bicarbonate SCHEMBL3691134 0.77 HPGD (0.55) ALDH1A1KMT2AMAPTHSD17B10LMNA
SCHEMBL8846903 0.76 HCAR2 (0.53) ALDH1A1KMT2AMAPTHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119341-A1 3-substituted oxyglutaric diester compound, optically active 3-substituted oxyglutaric monoester compound, and processes for producing these UBE INDUSTRIES, LTD. (JP) 2005-06-02 US disclosed
EP-1500642-A1 3-SUBSTITUTED OXYGLUTARIC DIESTER COMPOUND, OPTICALLY ACTIVE 3-SUBSTITUTED OXYGLUTARIC MONOESTER COMPOUND, AND PROCESSES FOR PRODUCING THESE Ube Industries, Ltd. (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119341-A1 3-substituted oxyglutaric diester compound, optically active 3-substituted oxyglutaric monoester compound, and processes for producing these OGDH, GLUL, ADSL ALDH1A1 434/4885KMT2A 2290/4885MAPT 3886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.